Phase II Open-Label Study of Taxoprexin (DHA-paclitaxel) Injection by 2-Hour Intravenous Infusion in Patients with Metastatic Hormone-Refractory Prostate Cancer

  • DOUKAS, MICHAEL (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date12/1/01 → 11/30/05